Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous decidual-like NK cells for reproductive failure with abnormal uterine NK cells
ChiCTR2500112495Phase 2Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Nov 2025
- Modality
- CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous decidual-like natural killer cells in infertility (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Ongoing pregnancy rate. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
autologous decidual-like natural killer cells
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2500112495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112495.